Dr. Fabrice Lucien-Matteoni is an Assistant Professor of Urology & Immunology at Mayo Clinic focused on liquid biopsies and next-gen cancer immunotherapies. He is also the Chair of the EV Blood Task Force.
His research is focused on developing non-invasive blood and urine tests that can facilitate cancer detection and prediction of response to specific therapies for individual patients. In addition, Dr. Lucien-Matteoni is focused on understanding the tumor-intrinsic mechanisms of immune evasion and resistance to cancer therapies. His work serves as a scientific foundation for the development of novel targeted therapies and immunotherapies for the treatment of human cancers.
